XCSE
NNIT
Market cap139mUSD
Oct 07, Last price
37.30DKK
1D
10.19%
1Q
1.50%
Jan 2017
-81.72%
IPO
-76.24%
Name
Nnit A/S
Chart & performance
P/E
—
P/S
0.52
EPS
—
Div yield, %
—
Shrs. gr., 5y
-0.02%
Rev. gr., 5y
-8.77%
Revenues
1.79b
-3.40%
Net income
-24m
L
CFO
-18m
L+200.00%
Dividend
Mar 11, 20211 DKK/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
NNIT A/S provides information technology solutions for life sciences, public, and private sectors in Denmark, Europe, the United States, and Asia. The company provides cybersecurity, regulatory affairs, AI, laboratory, drug safety, compliance, quality, SAP solutions, software engineering, digital manufacturing, clinical, data and cloud, supply chain, tech transition consulting, legacy transformation, and first-time launch services, as well as Microsoft and Veeva solutions, and migration solutions by valiance. NNIT A/S was founded in 1994 and is headquartered in Copenhagen, Denmark.
Key people
Jacob Hahn Michelsen
Senior Vice President - Private & Public · since 2019
Peter H.J. Haahr
Deputy Chairman of the Board · since 2017
Director · since 2018
Caroline Serfass
Independent Director · since 2018
Headquarters & legal address
Weidekampsgade 14
København S, 84 2300
DK
København S, 84 2300
DK
Address
Weidekampsgade 14
Kobenhavn S, 84 2300
DK
Kobenhavn S, 84 2300
DK
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||